April 1, 2021
Clinical Preventive Service Use Varies Across the United States
THURSDAY, April 1, 2021 (HealthDay News) — Use of recommended clinical preventive services varies across the United States, with insurance status being the dominant factor associated with service use, according to research published in the April 2 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Suhang Song, Ph.D.,...
Sickle Cell Disease and Risk Factors for Vasculopathy
Vasculopathy is a common complication of sickle cell disease (SCD) that can result in end-organ damage. Leg ulcers have been reported in 5-10% of adults with SCD. A lack of information exists about the geographic distribution of patients with SCD with reported leg ulcers. An analysis was necessary to determine how geographic location affects the...
Perceptions of Medical Racism in Sickle Cell Disease Care
It is a brutal truth that Black patients generally face worse health outcomes than their white counterparts, even when adjusting for insurance coverage and socioeconomic status. The majority of individuals with sickle cell disease (SCD) are Black and suffer from health inequity. This study investigated this correlation by distributing a survey on race and healthcare...
Disparate Funding for Sickle Cell Disease vs. Cystic Fibrosis
Sickle cell disease (SCD) and cystic fibrosis (CF) are both serious disorders that are inherited recessively and can greatly impact health outcomes and quality of life. The majority of individuals with SCD are Black, and the majority of patients with CF are white. While SCD and CF have relatively similar profiles in terms of inheritance...
Sickle Cell Disease and COVID-19
Sickle cell disease (SCD) is a serious condition that disproportionately affects Black individuals, affecting 1 out of every 365 Black Americans. This hemoglobinopathy puts individuals at risk of developing pulmonary complications. Because of this fact, it is believed that SCD can increase the risk of COVID-19. However, little research has been done to study the...
Endocrine Society, March 20-23
The annual meeting of the Endocrine Society was held virtually this year from March 20 to 23 and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, growth hormone,...
Readmission, Mortality Up After Discharge for Acute COVID-19
THURSDAY, April 1, 2021 (HealthDay News) — Individuals discharged from the hospital after acute COVID-19 have an increased risk for hospital readmission and mortality, according to a study published online March 31 in The BMJ. Daniel Ayoubkhani, from the Office for National Statistics in Newport, Wales, and colleagues quantified rates of organ-specific dysfunction in individuals...
Weekly Semaglutide Bests Placebo for Greater Weight Loss
THURSDAY, April 1, 2021 (HealthDay News) — Once-weekly subcutaneous semaglutide results in significantly greater weight loss than placebo when used as adjunctive therapy over 68 weeks in adults with overweight or obesity, according to a study published online Feb. 24 in the Journal of the American Medical Association. Thomas A. Wadden, Ph.D., from University of...